CBUF:F:F-iShares V Public Limited Company - iShares MSCI World Health Care UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.923

Change

-0.01 (-0.19)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.50 (+1.85%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.88 (+1.73%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

+5.96 (+1.09%)

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.98 (+1.78%)

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+4.25 (+1.78%)

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.05B
VUAA:F Vanguard S&P 500 UCITS Acc

+1.41 (+1.45%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+1.21 (+1.24%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.09 (-1.11%)

USD 40.74B
0ZC:F Zscaler Inc

+0.20 (+0.13%)

USD 37.92B

ETFs Containing CBUF:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.89% 41% F 53% F
Dividend Return 0.63% 3% F 5% F
Total Return 5.52% 39% F 47% F
Trailing 12 Months  
Capital Gain 7.17% 30% F 48% F
Dividend Return 0.64% 2% F 4% F
Total Return 7.81% 30% F 43% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.73% N/A N/A 47% F
Dividend Return 0.82% N/A N/A 41% F
Total Return 0.09% N/A N/A 4% F
Risk Return Profile  
Volatility (Standard Deviation) 3.98% N/A N/A 99% N/A
Risk Adjusted Return 20.55% N/A N/A 50% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike